Search Results - "Cutter, Gary R."

Treatment for Mild Chronic Hypertension during Pregnancy by Tita, Alan T., Szychowski, Jeff M., Boggess, Kim, Dugoff, Lorraine, Sibai, Baha, Lawrence, Kirsten, Hughes, Brenna L., Bell, Joseph, Aagaard, Kjersti, Edwards, Rodney K., Gibson, Kelly, Haas, David M., Plante, Lauren, Metz, Torri, Casey, Brian, Esplin, Sean, Longo, Sherri, Hoffman, Matthew, Saade, George R., Hoppe, Kara K., Foroutan, Janelle, Tuuli, Methodius, Owens, Michelle Y., Simhan, Hyagriv N., Frey, Heather, Rosen, Todd, Palatnik, Anna, Baker, Susan, August, Phyllis, Reddy, Uma M., Kinzler, Wendy, Su, Emily, Krishna, Iris, Nguyen, Nicki, Norton, Mary E., Skupski, Daniel, El-Sayed, Yasser Y., Ogunyemi, Dotum, Galis, Zorina S., Harper, Lorie, Ambalavanan, Namasivayam, Geller, Nancy L., Oparil, Suzanne, Cutter, Gary R., Andrews, William W.

“…Pregnant women with mild chronic hypertension were randomly assigned to receive medication targeting a normal blood pressure (<140/90 mm Hg) or to receive no…”
Get full text

Longitudinal Changes in Cognitive Test Scores in Patients With Relapsing-Remitting Multiple Sclerosis: An Analysis of the DECIDE Dataset by Castrogiovanni, Nina, Mostert, Jop, Repovic, Pavle, Bowen, James D, Uitdehaag, Bernard M J, Strijbis, Eva M M, Cutter, Gary R, Koch, Marcus W

“…Cognitive impairment is a common and impactful symptom of relapsing-remitting multiple sclerosis (RRMS). Cognitive outcome measures are often used in…”
Get full text

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG) by Muppidi, Srikanth, Guptill, Jeffrey T, Jacob, Saiju, Li, Yingkai, Farrugia, Maria E, Guidon, Amanda C, Tavee, Jinny O, Kaminski, Henry, Howard, James F, Cutter, Gary, Wiendl, Heinz, Maas, Matthew B, Illa, Isabel, Mantegazza, Renato, Murai, Hiroyuki, Utsugisawa, Kimiaki, Nowak, Richard J, Guidon, Amanda C, Tyagi, Alok, Sousa, Ana Paula, Amato, Anthony A, Pinto, Ashwin, Roy, Bhaskar, Carmichael, Caroline, Dodig, Dubravka, Burke, Georgina, Cutter, Gary R, Kaminski, Henry J, Wiendl, Heinz, Murai, Hiroyuki, Lee, Ikjae, Illa, Isabel, Guptill, Jeffrey, Howard, James F., Caress, James, Pritchard, Jane, Tavee, Jinny O, Vissing, John, Best, Kamla, Utsugisawa, Kimiaki, Ramezani, Mahtab, Maas, Mathew, Farrugia, Maria E, Hehir, Michael K, Kaku, Michelle, Esquivel, Natalia Jiménez, Gallagher, Paul, Maddison, Paul, Ambrose, Philip A, Mantegazza, Renato E, Nowak, Richard J, Do Campo, Rocio Vazquez, Jacob, Saiju, Saba, Sami, Nafissi, Shahriar, Itoyama, Shannon, Muppidi, Srikanth, Viegas, Stuart Viegas, Marshall, Victoria, Li, Yingkai Li

Get full text

Randomized study combining interferon and glatiramer acetate in multiple sclerosis by Lublin, Fred D., Cofield, Stacey S., Cutter, Gary R., Conwit, Robin, Narayana, Ponnada A., Nelson, Flavia, Salter, Amber R., Gustafson, Tarah, Wolinsky, Jerry S.

“…Objective A double‐blind, randomized, controlled study was undertaken to determine whether combined use of interferon β‐1a (IFN) 30μg intramuscularly weekly…”
Get full text

Using practice effects for targeted trials or sub-group analysis in Alzheimer's disease: How practice effects predict change over time by Wang, Guoqiao, Kennedy, Richard E, Goldberg, Terry E, Fowler, Mackenzie E, Cutter, Gary R, Schneider, Lon S

“…To describe the presence of practice effects in persons with Alzheimer disease (AD) or mild cognitive impairment (MCI) and to evaluate how practice effects…”
Get full text

Brief Report: Intracellular Cystatin B Levels Are Altered in HIV-Infected Participants With Respect to Neurocognitive Status and Antiretroviral Therapy by Opsteen, Skye, Moylan, David, Taiwo, Babafemi O., Robertson, Kevin R., Overton, E. Turner, Cutter, Gary R., Sabbaj, Steffanie, Heath, Sonya L., Shacka, John J.

“…With advances in HIV treatment, people with HIV (PWH) are living longer but experience aging-related comorbidities, including cognitive deficits, at higher…”
Get full text

Ketone monoester attenuates oxygen desaturation during weighted ruck exercise under acute hypoxic exposure but does not impact cognitive performance by McClure, Tyler S., Phillips, Jeffrey, Kernagis, Dawn, Coleman, Kody, Chappe, Ed, Cutter, Gary R., Egan, Brendan, Norell, Todd, Stubbs, Brianna J., Bamman, Marcas M., Koutnik, Andrew P.

“…Acute ingestion of exogenous ketone supplements in the form of a (R)‐3‐hydroxybutyl (R)‐3‐hydroxybutyrate (R‐BD R‐βHB) ketone monoester (KME) can attenuate…”
Get full text

Ketone monoester attenuates declines in cognitive performance and oxygen saturation during acute severe hypoxic exposure under resting conditions by McClure, Tyler S., Phillips, Jeffrey, Koutnik, Andrew P., Coleman, Kody, Chappe, Ed, Cutter, Gary R., Egan, Brendan, Norell, Todd, Stubbs, Brianna J., Bamman, Marcas M., Kernagis, Dawn

“…Exogenous ketone supplements are a potential augmentation strategy for cognitive resilience during acute hypoxic exposure due to their capacity to attenuate…”
Get full text

Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis by Talman, Lauren S., Bisker, Esther R., Sackel, David J., Long Jr, David A., Galetta, Kristin M., Ratchford, John N., Lile, Deacon J., Farrell, Sheena K., Loguidice, Michael J., Remington, Gina, Conger, Amy, Frohman, Teresa C., Jacobs, Dina A., Markowitz, Clyde E., Cutter, Gary R., Ying, Gui-Shuang, Dai, Yang, Maguire, Maureen G., Galetta, Steven L., Frohman, Elliot M., Calabresi, Peter A., Balcer, Laura J.

“…Objective Cross‐sectional studies of optical coherence tomography (OCT) show that retinal nerve fiber layer (RNFL) thickness is reduced in multiple sclerosis…”
Get full text

Challenging Assumptions About African American Participation in Alzheimer Disease Trials by Kennedy, Richard E., M.D., Ph.D, Cutter, Gary R., Ph.D, Wang, Guoqiao, Ph.D, Schneider, Lon S., M.D., M.S

“…Objective The authors investigated potential effects of increased African American participation in Alzheimer disease (AD) and mild cognitive impairment (MCI)…”
Get full text

Impact of Refractory Myasthenia Gravis on Health-Related Quality of Life by Boscoe, Audra N, Xin, Haichang, LʼItalien, Gilbert J, Harris, Linda A, Cutter, Gary R

“…OBJECTIVES:Myasthenia gravis (MG) may be refractory to traditional therapies. Quality of life (QOL) and disease burden in patients with refractory and…”
Get full text

Attitudes of people with multiple sclerosis toward brain donation by Marrie, Ruth Ann, Kosowan, Leanne, Cutter, Gary R, Fox, Robert J, Salter, Amber

“…Research directly examining brain tissue has played an important role in understanding the pathology and pathogenesis of multiple sclerosis (MS) and other…”
Get full text

Minimal manifestation status and prednisone withdrawal in the MGTX trial by Lee, Ikjae, Kuo, Hui-Chien, Aban, Inmaculada B., Cutter, Gary R., McPherson, Tarrant, Kaminski, Henry J., Sussman, Jon, Ströbel, Philipp, Oger, Joel, Cea, Gabriel, Heckmann, Jeannine M., Evoli, Amelia, Nix, Wilfred, Ciafaloni, Emma, Antonini, Giovanni, Witoonpanich, Rawiphan, King, John O., Beydoun, Said R., Chalk, Colin H., Barboi, Alexandru C., Amato, Anthony A., Shaibani, Aziz I., Katirji, Bashar, Lecky, Bryan R.F., Buckley, Camilla, Vincent, Angela, Dias-Tosta, Elza, Yoshikawa, Hiroaki, Waddington-Cruz, Marcia, Pulley, Michael T., Rivner, Michael H., Kostera-Pruszczyk, Anna, Pascuzzi, Robert M., Jackson, Carlayne E., Verschuuren, Jan J.G., Massey, Janice M., Kissel, John T., Werneck, Lineu C., Benatar, Michael, Barohn, Richard J., Tandan, Rup, Mozaffar, Tahseen, Conwit, Robin, Minisman, Greg, Sonett, Joshua R., Wolfe, Gil I.

“…OBJECTIVETo examine whether sustained minimal manifestation status (MMS) with complete withdrawal of prednisone is better achieved in thymectomized patients…”
Get full text

Inhaled Nitric Oxide in Preterm Infants: An Individual-Patient Data Meta-analysis of Randomized Trials by ASKIE, Lisa M, BALLARD, Roberta A, RICH, Wade, SCHREIBER, Michael D, WONGSIRIDEJ, Pimol (srisuparp), SUBHEDAR, Nim V, VAN MEURS, Krisa P, VOYSEY, Merryn, BARRINGTON, Keith, EHRENKRANZ, Richard A, FINER, Neil N, CUTTER, Gary R, DANI, Carlo, ELBOURNE, Diana, FIELD, David, HASCOET, Jean-Michel, HIBBS, Anna Maria, KINSELLA, John P, MERCIER, Jean-Christophe

“…Inhaled nitric oxide (iNO) is an effective therapy for pulmonary hypertension and hypoxic respiratory failure in term infants. Fourteen randomized controlled…”
Get full text

Less is more, or almost as much: A 15-item quality-of-life instrument for myasthenia gravis by Burns, Ted M., Conaway, Mark R., Cutter, Gary R., Sanders, Donald B.

“…We describe the process whereby a recently developed myasthenia gravis (MG)‐specific quality‐of‐life (QOL) instrument was reduced from 60 items to 15 items…”
Get full text

Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease by Kennedy, Richard E, Cutter, Gary R, Schneider, Lon S

“…Abstract Background The apolipoprotein E ( APOE ) ε4 genotype has been recommended as a potential inclusion or exclusion criterion in targeted clinical trials…”
Get full text

Construction of an efficient evaluative instrument for Myasthenia Gravis: The MG composite by Burns, Ted M., Conaway, Mark R., Cutter, Gary R., Sanders, Donald B.

“…We assessed the performance of items from the Quantitative Myasthenia Gravis (QMG), MMT (Manual Muscle Test), and MG‐ADL (Myasthenia Gravis – Activities of…”
Get full text

Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis by Marrie, Ruth Ann, Dolovich, Casandra, Cutter, Gary R, Fox, Robert J, Salter, Amber

“…Since the properties of health-related quality of life measures vary across samples, studies directly comparing the properties of different measures can be…”
Get full text

Effects of Early Inhaled Nitric Oxide Therapy and Vitamin A Supplementation on the Risk for Bronchopulmonary Dysplasia in Premature Newborns with Respiratory Failure by Gadhia, Monika M., MD, Cutter, Gary R., PhD, Abman, Steven H., MD, Kinsella, John P., MD

“…Objective To assess whether the combination of early inhaled nitric oxide (iNO) therapy and vitamin A supplementation lowers the incidence of bronchopulmonary…”
Get full text

Noninvasive Inhaled Nitric Oxide Does Not Prevent Bronchopulmonary Dysplasia in Premature Newborns by Kinsella, John P., MD, Cutter, Gary R., PhD, Steinhorn, Robin H., MD, Nelin, Leif D., MD, Walsh, William F., MD, Finer, Neil N., MD, Abman, Steven H., MD

“…Objective To assess the efficacy and safety of early, noninvasive inhaled nitric oxide (iNO) therapy in premature newborns who do not require mechanical…”
Get full text